Skip to Main Content

Author Details

Charles S Dela Cruz
Department of Microbial Pathogenesis Yale University New Haven
1998
197
48
Richard Andrew Taylor (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35665001A dual role for CRTH2 in acute lung injury.bioRxiv2024
35976979Adding Insult to Injury: Does COVID-19 Promote Acute Respiratory Distress Syndrome by Inhibiting Surfactant?Am J Respir Crit Care Med2023
37748514Distinguishing features of long COVID identified through immune profiling.Nature2023
37493348A Multiclass Radiomics Method-Based WHO Severity Scale for Improving COVID-19 Patient Assessment and Disease Characterization From CT Scans.Invest Radiol2023
37085229The Impact of Coronavirus Disease 2019 on Viral, Bacterial, and Fungal Respiratory Infections.Clin Chest Med2023
37085221Immunomodulatory Agents for Coronavirus Disease-2019 Pneumonia.Clin Chest Med2023
37009190Integrated Analysis of Tracheobronchial Fluid from Before and After Cardiopulmonary Bypass Reveals Activation of the Integrated Stress Response and Altered Pulmonary Microvascular Permeability.Yale J Biol Med2023
37009016Management of nontuberculous mycobacteria in lung transplant cases: an international Delphi study.ERJ Open Res2023
37163015Single-cell profiling reveals immune aberrations in progressive idiopathic pulmonary fibrosis.medRxiv2023
36626225microRNA-33 deficiency in macrophages enhances autophagy, improves mitochondrial homeostasis, and protects against lung fibrosis.JCI Insight2023
36856712Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria: An Official American Thoracic Society Workshop Report.Ann Am Thorac Soc2023
36815942Nonutility of procalcitonin for diagnosing bacterial pneumonia in patients with severe COVID-19.Eur Clin Respir J2023
36517181Identification of two specific transcriptomic clusters of COVID-19 acute respiratory distress syndrome patients with different immune profiles and different outcomes.Eur Respir J2023
36646089Glucocorticoid Therapy in COVID-19.Semin Respir Crit Care Med2023
36646080COVID-19.Semin Respir Crit Care Med2023
36828654Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial.BMJ Open2023
36763591Coronaviruses, Lysosomes, and Secondary Bacterial Infections: Coronaviruses Outsmart the Host.DNA Cell Biol2023
36596303PD-1<sup>high</sup>CXCR5<sup>-</sup>CD4<sup>+</sup> peripheral helper T cells promote CXCR3<sup>+</sup> plasmablasts in human acute viral infection.Cell Rep2023
34718647Longitudinal Immune Profiling of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection in a Solid Organ Transplant Recipient.J Infect Dis2022
35353672Summary for Clinicians: Clinical Practice Guideline for the Use of Nucleic Acid-based Testing for Noninfluenza Viral Pathogens in Adults with Suspected Community-acquired Pneumonia.Ann Am Thorac Soc2022
35411344Nonutility of procalcitonin for diagnosing bacterial pneumonia in COVID-19.medRxiv2022
35837790A practical treatment for COVID-19 and the next pandemic.Pharmacol Res Perspect2022
35609110No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination.PLoS Biol2022
35757815Development of an efficient reproducible cell-cell transmission assay for rapid quantification of SARS-CoV-2 spike interaction with hACE2.Cell Rep Methods2022
35483356Tissue remodeling by an opportunistic pathogen triggers allergic inflammation.Immunity2022
37396530A controlled random gene perturbation method identifies <i>ARPC1B</i> gene as a key regulator of cancer metastasis.Genes Dis2022
35998281Saracatinib, a Selective Src Kinase Inhibitor, Blocks Fibrotic Responses in Preclinical Models of Pulmonary Fibrosis.Am J Respir Crit Care Med2022
36165196Coronavirus Lung Infection Impairs Host Immunity against Secondary Bacterial Infection by Promoting Lysosomal Dysfunction.J Immunol2022
35245248New testing guidelines for community-acquired pneumonia.Curr Opin Infect Dis2022
35064122Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19.Nat Commun2022
35196896Emerging insights in sarcoidosis: moving forward through reverse translational research.Am J Physiol Lung Cell Mol Physiol2022
35228707Multiscale PHATE identifies multimodal signatures of COVID-19.Nat Biotechnol2022
35103557Update on the Features and Measurements of Experimental Acute Lung Injury in Animals: An Official American Thoracic Society Workshop Report.Am J Respir Cell Mol Biol2022
34644520Postnatal Sepsis and Bronchopulmonary Dysplasia in Premature Infants: Mechanistic Insights into "New BPD".Am J Respir Cell Mol Biol2022
34705554Distinct Roles of Type I and Type III Interferons during a Native Murine β Coronavirus Lung Infection.J Virol2022
34521729Association of circulating cell-free double-stranded DNA and metabolic derangements in idiopathic pulmonary fibrosis.Thorax2022
33093124Mitochondrial antiviral signaling protein is crucial for the development of pulmonary fibrosis.Eur Respir J2021
35373072Evidence for SARS-CoV-2 Spike Protein in the Urine of COVID-19 Patients.Kidney3602021
33655244Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection.bioRxiv2021
33493557Repetitive aeroallergen challenges elucidate maladaptive epithelial and inflammatory traits that underpin allergic airway diseases.J Allergy Clin Immunol2021
33851886Elevated IL-15 concentrations in the sarcoidosis lung are independent of granuloma burden and disease phenotypes.Am J Physiol Lung Cell Mol Physiol2021
33625952RIPK3 Activates MLKL-mediated Necroptosis and Inflammasome Signaling during <i>Streptococcus</i> Infection.Am J Respir Cell Mol Biol2021
33902571Single-cell characterization of a model of poly I:C-stimulated peripheral blood mononuclear cells in severe asthma.Respir Res2021
33788846Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection.PLoS One2021
33537037Editorial: Outsmarting the Host: How Bacterial Pathogens Modulate Immune Responses in the Lung.Front Immunol2021
33755009Increased SARS-CoV-2 Testing Capacity with Pooled Saliva Samples.Emerg Infect Dis2021
33754989Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva.Emerg Infect Dis2021
33891889Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children.Immunity2021
33861166Monoclonal Antibodies: Medical Uses for the Prevention and Treatment of Disease.Am J Respir Crit Care Med2021
33635335A neutrophil activation signature predicts critical illness and mortality in COVID-19.Blood Adv2021
  • 1 - 50 of 197

Recommended Authors

Soner Yildiz
University of Geneva
Career Start Year 2014
Number of shared co-authors 0
Kenneth E Remy
Rainbow Babies and Children's Hospital
Career Start Year 2012
Number of shared co-authors 0
Wei-Jie Guan
The Second Affiliated Hospital of Xiamen Medical College
Career Start Year 2011
Number of shared co-authors 0
Jeffrey M Sturek
University of Virginia
Career Start Year 2010
Number of shared co-authors 0
Matthew C Altman
University of Washington School of Medicine, Seattle Benaroya Research Institute
Career Start Year 2007
Number of shared co-authors 4
Carmen Mikacenic
Benaroya Research Institute at Virginia Mason
Career Start Year 2007
Number of shared co-authors 7
Daniel S Chertow
Clinical Center (CC)
Career Start Year 2006
Number of shared co-authors 0
Amber M Smith
University of California san francisco
Career Start Year 2006
Number of shared co-authors 0
John Kenneth Baillie
Roslin Institute, University of Edinburgh
Career Start Year 2005
Number of shared co-authors 7
Erin M Wilfong
Vanderbilt University Medical Center
Career Start Year 2005
Number of shared co-authors 1
April K Randhawa
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 1
Ho Namkoong
Keio University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Angela Meier
university of california san diego Department of Anesthesiology
Career Start Year 2003
Number of shared co-authors 0
Patrick J Danaher
NanoString Technologies Inc.
Career Start Year 2002
Number of shared co-authors 0
Peggy S Lai
Harvard Medical School
Career Start Year 2002
Number of shared co-authors 1
Robert J Freishtat
Center for Genetic Medicine Research, Children's National Research Institute
Career Start Year 2002
Number of shared co-authors 2
Lisa E Gralinski
University of North Carolina at Chapel Hill
Career Start Year 2002
Number of shared co-authors 1
Carrie M Rosenberger
Genentech Inc.
Career Start Year 2000
Number of shared co-authors 3
Paul G Thomas
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 2
Michelle A Gill
University of Rochester Medical Center
Career Start Year 1999
Number of shared co-authors 0
Rebecca M Baron
Brigham and Women's Hospital
Career Start Year 1997
Number of shared co-authors 9
Kristina L Bailey
College of Medicine, University of Nebraska Medical Center
Career Start Year 1997
Number of shared co-authors 1
David M Aronoff
Indiana University School of Medicine
Career Start Year 1997
Number of shared co-authors 0
Onn Min Kon
Chest & Allergy clinic, Imperial College Healthcare NHS Trust, St Mary's Hospital
Career Start Year 1996
Number of shared co-authors 0
Dat Tran
Oregon Health Authority
Career Start Year 1995
Number of shared co-authors 2
Rodrigo Andres Floto
University of Cambridge
Career Start Year 1995
Number of shared co-authors 0
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 1993
Number of shared co-authors 2
Mahdad Noursadeghi
University College London
Career Start Year 1992
Number of shared co-authors 1
Octavio Ramilo
St. Jude Children's Research Hospital
Career Start Year 1986
Number of shared co-authors 1
Nanshan Zhong
Kunming University of Science and Technology
Career Start Year 1984
Number of shared co-authors 1

Collaborators

Shelli F Farhadian
Yale School of Medicine
Co-authored papers 22
Albert I Ko
Instituto Goncalo Moniz, Yale School of Public Health
Co-authored papers 22
Akiko Iwasaki
Yale University
Co-authored papers 19
Arnau Casanovas-Massana
School of Public Health, Yale University
Co-authored papers 16
Santos Bermejo
Yale University
Co-authored papers 16
Nathan D Grubaugh
Yale School of Public Health
Co-authored papers 14
Chantal B F Vogels
Yale School of Public Health
Co-authored papers 14
Anne L Wyllie
Yale School of Public Health
Co-authored papers 14
Richard G Wunderink
Northwestern University Feinberg School of Medicine
Co-authored papers 11
Carolina Lucas
Yale School of Medicine
Co-authored papers 9
Patrick Wong
Yale School of Medicine
Co-authored papers 9
Tianyang Mao
Yale University School of Medicine
Co-authored papers 8
Maria Tokuyama
Yale University School of Medicine
Co-authored papers 8
Peiwen Lu
Yale University School of Medicine
Co-authored papers 8
Saad B Omer
Yale School of Public Health
Co-authored papers 7
Benjamin Israelow
Yale University School of Medicine
Co-authored papers 7
Grant W Waterer
University of Western Australia, Royal Perth Hospital
Co-authored papers 7
David van Dijk
Yale School of Medicine, Yale University
Co-authored papers 7
Aaron M Ring
Yale University School of Medicine
Co-authored papers 7
Alfred I Lee
Yale University School of Medicine
Co-authored papers 7
Hyung J Chun
Yale Cardiovascular Research Center, Yale University School of Medicine
Co-authored papers 6
John Fournier
Yale University
Co-authored papers 6
M Catherine Muenker
Yale School of Public Health
Co-authored papers 6
Albert C Shaw
Yale School of Medicine, Yale University
Co-authored papers 6
Arvind Venkataraman
Christian Medical College
Co-authored papers 6
Adam J Moore
Yale School of Public Health
Co-authored papers 6
Isabel M Ott
Yale School of Public Health
Co-authored papers 6
Ji Eun Oh
College of Science & Industry Convergence, Ewha Womans University
Co-authored papers 6
Craig B Wilen
Yale School of Medicine
Co-authored papers 5
David A Hafler
Yale School of Medicine, Yale School of Public Health
Co-authored papers 5
Release 1.2